Source: Annual Congress 2001 - Mechanisms of airway inflammation in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. L. Videnovic-Ivanov, J. A. Djordjevic, V. M. Vucinic-Mihajlovic (Belgrade, Yugoslavia). Role of antioxidant in patients with COPD. Eur Respir J 2001; 16: Suppl. 31, 1699

Member's Comments

No comment yet.

Related content which might interest you: Monitoring antioxidant enzyme activity in patients with COPD exacerbations Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Relationship between peroxidation and antioxidant status in induced sputum and BODE-index in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 Inflammation markers and antioxidant activity in patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 217s Year: 2001 Effect of pulmonary rehabilitation on erythrocyte oxidative stress and antioxidants in COPD patients Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 Lipid peroxidation and antioxidative enzymes in patients with COPD: relationship to pulmonary hyperinflation Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Antioxidant defence in acute exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Parameters of antioxidant protection in patients with lung sarcoidosis Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 Effect of smoking on antioxidant defence and lipid peroxidation in patients with chronic obstructive bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 390s Year: 2005 Effect of smoking on the antioxidant defense and lipid peroxidation in patients with chronic obstructive bronchitis Source: Eur Respir J 2003; 22: Suppl. 45, 306s Year: 2003 Evaluation of vasomotor substances in COPD patients Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Systemic antioxidant status in Chinese patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 509s Year: 2004 Effect of suplementary dietary antioxidants in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006 Effects of lisinipril on hypertensive COPD and asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 718s Year: 2005 Effect of erdosteine in moderately severe COPD patients Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Long-term use of antioxidant mucolytic erdosteine is especially beneficial in patients with more severe COPD Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Effects of Hochuekkito combined with pulmonary rehabilitation in patients with COPD Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 Antioxidant status and pulmonary function in patients with chronic airflow limitation Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003 Increased oxidative stress and altered antioxidant status in Chinese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 62s Year: 2004 Rosuvastatin effects on systemic inflammation, oxidative stress and antioxidants in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016